about
Targeting mesenchymal stem cells to activated endothelial cells.Trimethylated chitosans as non-viral gene delivery vectors: cytotoxicity and transfection efficiency.Serial transplantation and long-term engraftment of intra-arterially delivered clonally derived mesenchymal stem cells to injured bone marrow.Synoviocyte Derived-Extracellular Matrix Enhances Human Articular Chondrocyte Proliferation and Maintains Re-Differentiation Capacity at Both Low and Atmospheric Oxygen Tensions.Can Cytoprotective Cobalt Protoporphyrin Protect Skeletal Muscle and Muscle-derived Stem Cells From Ischemic Injury?Acceptance criteria for levels of hydrazine in substances for pharmaceutical use and analytical methods for its determination.Optimizing mesenchymal stem cell-based therapeutics.Biodegradation, biodistribution and toxicity of chitosan.MSCs: Delivery Routes and Engraftment, Cell-Targeting Strategies, and Immune Modulation.Disparate response of articular- and auricular-derived chondrocytes to oxygen tension.Correction: Synoviocyte Derived-Extracellular Matrix Enhances Human Articular Chondrocyte Proliferation and Maintains Re-Differentiation Capacity at Both Low and Atmospheric Oxygen Tensions.Thyroxine Increases Collagen Type II Expression and Accumulation in Scaffold-Free Tissue-Engineered Articular Cartilage.Tissue engineering of a composite trachea construct using autologous rabbit chondrocytes.Reduced bone loss in a murine model of postmenopausal osteoporosis lacking complement component 3.A comparison of five treatment protocols for contaminated bone grafts in reference to sterility and cell viability.Transcriptome-Wide Analysis of Human Chondrocyte Expansion on Synoviocyte MatrixRapid Detection of Shear-Induced Damage in Tissue-Engineered Cartilage Using Ultrasound
P50
Q30488087-973FCADA-28C8-4C0B-B9FB-FC28EE562328Q34410118-79C4099C-B4EB-4359-B857-3175DF111DABQ34997877-B8244221-8BD0-4799-B3A6-21F4D7D7F20DQ35663807-71F0D9BC-D22B-42D9-A747-E449B859D91EQ35912367-340F56AA-40F4-4E4A-865B-F536484D487DQ36906784-6C4FA688-515B-4C4E-954A-A49167E2B8BAQ37604019-4B9FADE8-A3E0-4064-B8BD-B64B92CF78F9Q37607576-DDB41E24-F9A2-40EC-9057-D90D590BBAB8Q39356606-6B25A63D-025C-4A11-9513-592C3E1BEDB2Q42357665-CBF9A910-E53B-4D06-ACB8-C566EFA04AE9Q43236254-E80D9A4A-2330-43E6-A723-88C927F17198Q47574994-F1E1B70E-DF4B-4EBE-AE9F-D99A06794AD2Q47910783-3F40B005-5C0B-411A-A003-F5D9D7B666B6Q48190620-0B55E7C9-B142-4C6D-825E-F88D5E5B0139Q50280534-4463E8EE-7F97-4477-B3E7-52DBB31DEB7BQ64243426-88E078AB-209F-46A0-8127-38C39D83625CQ89589561-8368840F-11F4-4F3E-AC8D-CF6DBC496106
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Thomas Kean
@ast
Thomas Kean
@en
Thomas Kean
@es
Thomas Kean
@nl
Thomas Kean
@sl
type
label
Thomas Kean
@ast
Thomas Kean
@en
Thomas Kean
@es
Thomas Kean
@nl
Thomas Kean
@sl
altLabel
Thomas J. Kean
@en
prefLabel
Thomas Kean
@ast
Thomas Kean
@en
Thomas Kean
@es
Thomas Kean
@nl
Thomas Kean
@sl
P106
P21
P31
P496
0000-0001-6844-3404